Mobia Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-46.5	-24.6
Depreciation & Amortization	0.15	0.12
Stock-Based Compensation	1.45	0.76
Other Adjustments	0.13	0.05
Change in Receivables	-1.61	-1.39
Changes in Inventories	-2.03	-0.25
Changes in Accounts Payable	1.08	-0.11
Changes in Accrued Expenses	4.24	1.39
Changes in Other Operating Activities	-2.61	-0.29
Operating Cash Flow	-45.7	-24.32
Capital Expenditures	-0.36	-0.04
Investing Cash Flow	-0.36	-0.04
Issuance of Common Stock	0.31	0.67
Net Common Stock Issued (Repurchased)	0.31	0.67
Issuance of Preferred Stock	64.71	14.99
Net Preferred Stock Issued (Repurchased)	64.71	14.99
Financing Cash Flow	65.03	15.66
Net Cash Flow	18.97	-8.7
Free Cash Flow	-46.06	-24.36
FCF Margin	-143.75%	-155.69%
Free Cash Flow Per Share	-54.26	-42.39
Levered Free Cash Flow	-46.03	-23.78
Unlevered Free Cash Flow	-45.9	-23.42

SEC Filings: 10-K · 10-Q